Aug 4, 2026 07:00AM
Aug 4, 2026 07:00AM
Jul 7, 2026 07:03AM
Jun 18, 2026 07:00AM
Jun 18, 2026 07:00AM
May 18, 2026 04:00PM
May 18, 2026 04:00PM Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
May 7, 2026 07:00AM
Apr 1, 2026 05:12PM
Apr 1, 2026 05:12PM
Mar 25, 2026 11:48AM
Mar 25, 2026 07:00AM
Mar 25, 2026 07:00AM
Mar 3, 2026 07:21AM H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
Feb 26, 2026 05:52AM
Feb 24, 2026 11:49AM
Feb 24, 2026 07:01AM
Jan 21, 2026 07:44AM
Jan 15, 2026 06:43AM
Jan 12, 2026 07:25AM
Jan 12, 2026 04:04AM Beam Therapeutics reaches FDA alignment on accelerated approval pathway
Jan 11, 2026 05:00PM
Dec 9, 2025 11:57AM
Nov 4, 2025 07:00AM
Oct 31, 2025 09:54AM
Aug 30, 2025 04:00PM
Aug 14, 2025 07:00AM
Aug 14, 2025 07:00AM Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
Aug 5, 2025 07:00AM
Jun 3, 2025 07:00AM
Jun 3, 2025 07:00AM
May 29, 2025 04:02PM
May 29, 2025 04:01PM
May 12, 2025 04:05PM
May 12, 2025 04:01PM Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
May 6, 2025 07:00AM
Apr 10, 2025 05:32AM
Apr 5, 2025 07:00AM
Mar 27, 2025 04:01PM
Mar 27, 2025 04:01PM
Mar 10, 2025 12:59PM
Mar 10, 2025 12:58PM Mizuho Reiterates Outperform Rating on WAVE Life Sciences (WVE)
Jan 13, 2025 07:04AM
Jan 13, 2025 07:00AM
Jan 6, 2025 02:00PM
Nov 5, 2024 09:00AM
Nov 5, 2024 06:30AM
Aug 6, 2024 06:30AM
Nov 8, 2023 06:30AM Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
Oct 25, 2023 06:30AM

327,753 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All